PyInvesting

Market research

2183.TSE Linical Co., Ltd

TSE JPY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
5B
P/E ratio
Not available
Analyst target
2700
Dividend yield
3.9%
Beta
0.38

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Linical Co., Ltd is currently in a long term uptrend where the price is trading 24.6% above its 200 day moving average.

From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.

Linical Co., Ltd's total revenue sank by 9.4% to $3B since the same quarter in the previous year.

Its net income has increased by 1.5% to $171M since the same quarter in the previous year.

Based on the above factors, Linical Co., Ltd gets an overall score of 3/5.